Clinical trial
Enhancing Conservative Treatment for Urge Incontinence
NCT00223821 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00223821 |
|---|---|
| Title | Enhancing Conservative Treatment for Urge Incontinence |
| Official title | Enhancing Conservative Treatment for Urge Incontinence |
| Acronym | COMBO |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Status | Completed |
| Study type | Interventional |
| Conditions | Urinary Incontinence |
| Intervention type | Behavioral, Drug |
| Interventions | Oxybutynin chloride, extended-release, individually-titrated, Behavior Training |
| Enrollment | 166 |
| Start date | Sep 1, 2003 |
| Primary completion | Nov 1, 2008 |
| Completion | Dec 1, 2009 |
| First posted | Sep 22, 2005 |
| Last update posted | Dec 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: